Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis

Nature Genetics

Volumn 44, Issue 5, 2012, Pages 522-525

  Lee, Yi Ching ^a,b   Kuo, Ho Chang ^c,d   Chang, Jeng Sheng ^e   Chang, Luan Yin ^f   Huang, Li Min ^f   Chen, Ming Ren ^g   Liang, Chi Di ^c,d   Chi, Hsin ^g   Huang, Fu Yuan ^g   Lee, Meng Luen ^h   Huang, Yhu Chering ^c,d   Hwang, Betau ⁱ   Chiu, Nan Chang ^g   Hwang, Kao Pin ^c,e,j   Lee, Pi Chang ^k   Chang, Li Ching ^a   Liu, Yi Min ^a   Chen, Ying Ju ^a   Chen, Chien Hsiun ^a,j   Chen, Yuan Tsong ^a,l   Tsai, Fuu Jen ^e,j,m   Wu, Jer Yuarn ^a,j   more..

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g MACKAY MEMORIAL HOSPITAL   (Taiwan)

^h CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

ⁱ TAIPEI CITY HOSPITAL   (Taiwan)

^j CHINA MEDICAL UNIVERSITY   (Taiwan)

^k TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^l DUKE UNIVERSITY MEDICAL CENTER   (United States)

^m ASIA UNIVERSITY   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOID TYROSINE KINASE; CD40 ANTIGEN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; GENETIC LOCI; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN;

EID: 84862814732     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2227     Document Type: Article

References (44)

1. Kato, H., Koike, S., Yamamoto, M., Ito, Y. & Yano, E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J. Pediatr. 86, 892-898 (1975).
2. Kato, H. et al. Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation 94, 1379-1385 (1996). (Pubitemid 26307269)
3. Yanagawa, H. et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics 102, E65 (1998).
4. Yanagawa, H. et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 107, E33 (2001).
5. Park, Y.W. et al. Epidemiological features of Kawasaki disease in Korea, 2006-2008. Pediatr. Int. 53, 36-39 (2011).
6. Chang, L.Y. et al. Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002. Pediatrics 114, e678-e682 (2004).
7. Huang, W.C. et al. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 123, e401-e405 (2009).
8. Matsubara, T., Furukawa, S. & Yabuta, K. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesions. Clin. Immunol. Immunopathol. 56, 29-36 (1990). (Pubitemid 20220882)
9. Lin, C.Y., Lin, C.C., Hwang, B. & Chiang, B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor α among patients with Kawasaki disease. J. Pediatr. 121, 924-926 (1992).
10. Onouchi, Y. Molecular genetics of Kawasaki disease. Pediatr. Res. 65, 46R-54R (2009).
11. Onouchi, Y. et al. A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J. Hum. Genet. 52, 179-190 (2007). (Pubitemid 46185112)
12. Onouchi, Y. et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat. Genet. 40, 35-42 (2008).
13. Burgner, D. et al. A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PLoS Genet. 5, e1000319 (2009).
14. Kim, J.J. et al. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease. Hum. Genet. 129, 487-495 (2011).
15. Tsai, F.J. et al. Identification of novel susceptibility loci for Kawasaki disease in a Han Chinese population by a genome-wide association study. PLoS ONE 6, e16853 (2011).
16. Khor, C.C. et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat. Genet. 43, 1241-1246 (2011).
17. Dymecki, S.M., Zwollo, P., Zeller, K., Kuhajda, F.P. & Desiderio, S.V. Structure and developmental regulation of the B-lymphoid tyrosine kinase gene blk. J. Biol. Chem. 267, 4815-4823 (1992).
18. Wasserman, R., Li, Y.S. & Hardy, R.R. Differential expression of the blk and ret tyrosine kinases during B lineage development is dependent on Ig rearrangement. J. Immunol. 155, 644-651 (1995).
19. Nemazee, D. & Weigert, M. Revising B cell receptors. J. Exp. Med. 191, 1813-1817 (2000). (Pubitemid 30390345)
20. Hom, G. et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 358, 900-909 (2008). (Pubitemid 351397089)
21. Gregersen, P.K. et al. REL, encoding a member of the NF-κB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat. Genet. 41, 820-823 (2009).
22. Peters, A.L., Stunz, L.L. & Bishop, G.A. CD40 and autoimmunity: the dark side of a great activator. Semin. Immunol. 21, 293-300 (2009).
23. Akiyama, T. et al. The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity 29, 423-437 (2008).
24. Iezzi, G. et al. CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells. Proc. Natl. Acad. Sci. USA 106, 876-881 (2009).
25. Jacobson, E.M. et al. A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun. 8, 205-214 (2007). (Pubitemid 46672053)
26. Wagner, D.H. Jr. et al. Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. Proc. Natl. Acad. Sci. USA 99, 3782-3787 (2002). (Pubitemid 34252183)
27. Gerritse, K. et al. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93, 2499-2504 (1996). (Pubitemid 26104798)
28. Ohta, Y. & Hamada, Y. In situ expression of CD40 and CD40 ligand in psoriasis. Dermatology 209, 21-28 (2004). (Pubitemid 39179101)
29. Danese, S. et al. TNF-α blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. J. Immunol. 176, 2617-2624 (2006). (Pubitemid 43201714)
30. Brennan, F.M. & McInnes, I.B. Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Invest. 118, 3537-3545 (2008).
31. Pyrovolaki, K. et al. Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosis. Arthritis Rheum. 60, 543-552 (2009).
32. Tomer, Y., Concepcion, E. & Greenberg, D.A. A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12, 1129-1135 (2002). (Pubitemid 36114821)
33. Ban, Y., Tozaki, T., Taniyama, M. & Tomita, M. Association of a C/T single-nucleotide polymorphism in the 5′ untranslated region of the CD40 gene with Graves' disease in Japanese. Thyroid 16, 443-446 (2006).
34. Kurylowicz, A. et al. Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease. Thyroid 15, 1119-1124 (2005). (Pubitemid 41720717)
35. Raychaudhuri, S. et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat. Genet. 40, 1216-1223 (2008).
36. Blanco-Kelly, F. et al. CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility. PLoS ONE 5, e11520 (2010).
37. Law, C.L. & Grewal, I.S. Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges. Adv. Exp. Med. Biol. 647, 8-36 (2009).
38. Hassan, G.S., Merhi, Y. & Mourad, W.M. CD154 and its receptors in inflammatory vascular pathologies. Trends Immunol. 30, 165-172 (2009).
39. Wang, C.L. et al. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Pediatrics 111, E140-E147 (2003).
40. Newburger, J.W. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114, 1708-1733 (2004). (Pubitemid 41754943)
41. Kim, S. & Dedeoglu, F. Update on pediatric vasculitis. Curr. Opin. Pediatr. 17, 695-702 (2005). (Pubitemid 41689660)
42. Pan, W.H. et al. Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Hum. Hered. 61, 27-30 (2006).
43. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006). (Pubitemid 44141658)
44. Higgins, J.P. & Thompson, S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539-1558 (2002). (Pubitemid 34746062)